DK3423081T3 - Sammensætninger til brug i behandlingen af neurologisk sygdom - Google Patents
Sammensætninger til brug i behandlingen af neurologisk sygdom Download PDFInfo
- Publication number
- DK3423081T3 DK3423081T3 DK17707869.8T DK17707869T DK3423081T3 DK 3423081 T3 DK3423081 T3 DK 3423081T3 DK 17707869 T DK17707869 T DK 17707869T DK 3423081 T3 DK3423081 T3 DK 3423081T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- treatment
- neurological disease
- neurological
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1603510.7A GB201603510D0 (en) | 2016-02-29 | 2016-02-29 | Compositions for use in the treatment of neurological disease |
| PCT/EP2017/054665 WO2017148960A1 (en) | 2016-02-29 | 2017-02-28 | Compositions for use in the treatment of neurological disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3423081T3 true DK3423081T3 (da) | 2021-10-18 |
Family
ID=55807091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17707869.8T DK3423081T3 (da) | 2016-02-29 | 2017-02-28 | Sammensætninger til brug i behandlingen af neurologisk sygdom |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20210196799A1 (da) |
| EP (1) | EP3423081B1 (da) |
| JP (1) | JP7492810B2 (da) |
| CA (1) | CA3016104A1 (da) |
| DK (1) | DK3423081T3 (da) |
| GB (1) | GB201603510D0 (da) |
| WO (1) | WO2017148960A1 (da) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6369193B1 (en) * | 1998-10-20 | 2002-04-09 | University Of Utah Research Foundation | Contulakin-G, analogs thereof and uses therefor |
| GB0717388D0 (en) * | 2007-09-07 | 2007-10-17 | Uutech Ltd | Use of GIP for the treatment of disorders associated with dysfunctional synaptic transmission |
| CN106928341B (zh) * | 2011-03-30 | 2021-06-01 | 上海仁会生物制药股份有限公司 | 定点单取代聚乙二醇化Exendin类似物及其制备方法 |
| WO2013104929A1 (en) * | 2012-01-12 | 2013-07-18 | University Of Ulster | Peptides and peptide derivatives based on xenin |
| TW201609795A (zh) * | 2013-12-13 | 2016-03-16 | 賽諾菲公司 | 作為雙重ｇｌｐ－１／ｇｉｐ受體促效劑的艾塞那肽－４（ｅｘｅｎｄｉｎ－４）胜肽類似物 |
| EP2997966A1 (en) * | 2014-09-16 | 2016-03-23 | Sanofi | Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders |
| KR20210145224A (ko) | 2019-03-28 | 2021-12-01 | 비트로 플랫 글래스 엘엘씨 | 낮은 가시광 반사율을 갖는 헤드-업 디스플레이를 위한 코팅 |
-
2016
- 2016-02-29 GB GBGB1603510.7A patent/GB201603510D0/en not_active Ceased
-
2017
- 2017-02-28 CA CA3016104A patent/CA3016104A1/en active Pending
- 2017-02-28 JP JP2018545661A patent/JP7492810B2/ja active Active
- 2017-02-28 US US16/080,911 patent/US20210196799A1/en not_active Abandoned
- 2017-02-28 WO PCT/EP2017/054665 patent/WO2017148960A1/en active Application Filing
- 2017-02-28 EP EP17707869.8A patent/EP3423081B1/en active Active
- 2017-02-28 DK DK17707869.8T patent/DK3423081T3/da active
-
2022
- 2022-12-08 US US18/063,494 patent/US20230181692A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3423081B1 (en) | 2021-07-14 |
| CA3016104A1 (en) | 2017-09-08 |
| US20210196799A1 (en) | 2021-07-01 |
| JP7492810B2 (ja) | 2024-05-30 |
| EP3423081A1 (en) | 2019-01-09 |
| US20230181692A1 (en) | 2023-06-15 |
| GB201603510D0 (en) | 2016-04-13 |
| WO2017148960A1 (en) | 2017-09-08 |
| JP2019512471A (ja) | 2019-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3347030T3 (da) | Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme | |
| MA45192A (fr) | Traitement d'association | |
| DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
| DK3364997T5 (da) | Aspartoacylase genterapi til behandling af canavans sygdom | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3326641T3 (da) | Rna-holdig sammensætning til behandling af tumorsygdomme | |
| DK3185876T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser | |
| DK3490582T3 (da) | Sammensætninger til anvendelse i behandling af myelofibrose | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| DK3307262T3 (da) | Forbindelser til anvendelse ved behandling af neuromuskulære lidelser | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3102213T3 (da) | Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser | |
| DK3302519T3 (da) | Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom | |
| DK3548061T3 (da) | Behandling af neurologiske sygdomme | |
| IT201600121601A1 (it) | Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo | |
| DK3192524T3 (da) | Hgf præparat egnet til behandling af neurologiske lidelser | |
| DK3157522T3 (da) | Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| DK3373931T3 (da) | Heterocykliske forbindelser til behandling af sygdom | |
| DK3302573T3 (da) | Sammensætning til behandlingen af hjernelæsioner | |
| DK3506901T3 (da) | Anvendelse af kynurensyre til behandling af muskelatrofi | |
| DK3423060T3 (da) | Imatinib til anvendelse til behandling af slagtilfælde | |
| DK3169405T3 (da) | Fremgangsmåder, forbindelser og sammensætninger til behandling af muskel- og skeletsygdomme | |
| DK3442558T3 (da) | Bmp-7-afledte peptider til anvendelse i behandlingen af osteoartritis | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme |